Skip to main content
Top
Published in: Endocrine 3/2017

01-09-2017 | Research Letter

Circulating neuregulin 4 concentrations in patients with newly diagnosed type 2 diabetes: a cross-sectional study

Authors: Lei Zhang, Yuming Fu, Nan Zhou, Xingbo Cheng, Chao Chen

Published in: Endocrine | Issue 3/2017

Login to get access

Excerpt

Accumulating findings have evidenced that adipose tissue-derived factors play crucial roles in the process of modulating systemic metabolism [1, 2]. Brown adipose tissue (BAT), traditionally known for consuming energy in response to cold [3], recently has been demonstrated to have an endocrine role in regulating fuel metabolism and energy balance [4–6]. Fibroblast growth factor 21(FGF21) and neuregulin 4 (Nrg4) are among the factors secreted by BAT [7, 8]. Wang et al. found that Nrg4 preserves glucose and lipid homeostasis through attenuating hepatic lipogenic signaling in obesity [8]. Another study via Nrg4 gene transfer in mice demonstrated that increased Nrg4 expression inhibits diet-induced chronic inflammation, improves insulin resistance, and prevents weight gain [9]. Moreover, circulating Nrg4 concentrations are inversely associated with the risk of metabolic syndrome in obese Chinese adults [10]. Controversially, Chen et al. found that circulating Nrg4 level was elevated in type 2 diabetes mellitus (T2DM) and showed positive correlation with adiposity index [11]. In this study, we aimed to assess the association between serum Nrg4 levels and T2DM. …
Literature
1.
go back to reference A. Parimisetty, A.C. Dorsemans, R. Awada, P. Ravanan, N. Diotel, C. Lefebvre d’Hellencourt, Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J. Neuroinflammation 13(1), 67 (2016). doi:10.1186/s12974-016-0530-x CrossRefPubMedPubMedCentral A. Parimisetty, A.C. Dorsemans, R. Awada, P. Ravanan, N. Diotel, C. Lefebvre d’Hellencourt, Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J. Neuroinflammation 13(1), 67 (2016). doi:10.​1186/​s12974-016-0530-x CrossRefPubMedPubMedCentral
5.
8.
go back to reference G.X. Wang, X.Y. Zhao, Z.X. Meng, M. Kern, A. Dietrich, Z. Chen, Z. Cozacov, D. Zhou, A.L. Okunade, X. Su, S. Li, M. Bluher, J.D. Lin, The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat. Med. 20(12), 1436–1443 (2014). doi:10.1038/nm.3713 CrossRefPubMedPubMedCentral G.X. Wang, X.Y. Zhao, Z.X. Meng, M. Kern, A. Dietrich, Z. Chen, Z. Cozacov, D. Zhou, A.L. Okunade, X. Su, S. Li, M. Bluher, J.D. Lin, The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat. Med. 20(12), 1436–1443 (2014). doi:10.​1038/​nm.​3713 CrossRefPubMedPubMedCentral
11.
go back to reference L.L. Chen, M.M. Peng, J.Y. Zhang, X. Hu, J. Min, Q.L. Huang, L.M. Wan, Elevated circulating neuregulin4 level in patients with diabetes. Diabetes Metab. Res. Rev. 33, e2870 (2016). doi:10.1002/dmrr.2870 L.L. Chen, M.M. Peng, J.Y. Zhang, X. Hu, J. Min, Q.L. Huang, L.M. Wan, Elevated circulating neuregulin4 level in patients with diabetes. Diabetes Metab. Res. Rev. 33, e2870 (2016). doi:10.​1002/​dmrr.​2870
12.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed
13.
go back to reference Y.C. Woo, C.H. Lee, C.H. Fong, A. Xu, A.W. Tso, B.M. Cheung, K.S. Lam, Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes. Clin. Endocrinol. 86(1), 37–43 (2017). doi:10.1111/cen.13229 CrossRef Y.C. Woo, C.H. Lee, C.H. Fong, A. Xu, A.W. Tso, B.M. Cheung, K.S. Lam, Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes. Clin. Endocrinol. 86(1), 37–43 (2017). doi:10.​1111/​cen.​13229 CrossRef
14.
go back to reference Y.E. Kang, J.M. Kim, S. Choung, K.H. Joung, J.H. Lee, H.J. Kim, B.J. Ku, Comparison of serum Neuregulin 4 (Nrg4) levels in adults with newly diagnosed type 2 diabetes mellitus and controls without diabetes. Diabetes Res. Clin. Pract. 117, 1–3 (2016). doi:10.1016/j.diabres.2016.04.007 CrossRefPubMed Y.E. Kang, J.M. Kim, S. Choung, K.H. Joung, J.H. Lee, H.J. Kim, B.J. Ku, Comparison of serum Neuregulin 4 (Nrg4) levels in adults with newly diagnosed type 2 diabetes mellitus and controls without diabetes. Diabetes Res. Clin. Pract. 117, 1–3 (2016). doi:10.​1016/​j.​diabres.​2016.​04.​007 CrossRefPubMed
15.
go back to reference D. Harari, E. Tzahar, J. Romano, M. Shelly, J.H. Pierce, G.C. Andrews, Y. Yarden, Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 18(17), 2681–2689 (1999). doi:10.1038/sj.onc.1202631 CrossRefPubMed D. Harari, E. Tzahar, J. Romano, M. Shelly, J.H. Pierce, G.C. Andrews, Y. Yarden, Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 18(17), 2681–2689 (1999). doi:10.​1038/​sj.​onc.​1202631 CrossRefPubMed
16.
go back to reference N.V. Hayes, E. Blackburn, M.M. Boyle, G.A. Russell, T.M. Frost, B.J. Morgan, W.J. Gullick, Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility. Endocr. Relat. Cancer. 18(1), 39–49 (2011). doi:10.1677/ERC-10-0112 CrossRefPubMed N.V. Hayes, E. Blackburn, M.M. Boyle, G.A. Russell, T.M. Frost, B.J. Morgan, W.J. Gullick, Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility. Endocr. Relat. Cancer. 18(1), 39–49 (2011). doi:10.​1677/​ERC-10-0112 CrossRefPubMed
17.
go back to reference M. Rosell, M. Kaforou, A. Frontini, A. Okolo, Y.W. Chan, E. Nikolopoulou, S. Millership, M.E. Fenech, D. MacIntyre, J.O. Turner, J.D. Moore, E. Blackburn, W.J. Gullick, S. Cinti, G. Montana, M.G. Parker, M. Christian, Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice. Am. J. Physiol. Endocrinol. Metab. 306(8), E945–E964 (2014). doi:10.1152/ajpendo.00473.2013 CrossRefPubMedPubMedCentral M. Rosell, M. Kaforou, A. Frontini, A. Okolo, Y.W. Chan, E. Nikolopoulou, S. Millership, M.E. Fenech, D. MacIntyre, J.O. Turner, J.D. Moore, E. Blackburn, W.J. Gullick, S. Cinti, G. Montana, M.G. Parker, M. Christian, Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice. Am. J. Physiol. Endocrinol. Metab. 306(8), E945–E964 (2014). doi:10.​1152/​ajpendo.​00473.​2013 CrossRefPubMedPubMedCentral
18.
Metadata
Title
Circulating neuregulin 4 concentrations in patients with newly diagnosed type 2 diabetes: a cross-sectional study
Authors
Lei Zhang
Yuming Fu
Nan Zhou
Xingbo Cheng
Chao Chen
Publication date
01-09-2017
Publisher
Springer US
Published in
Endocrine / Issue 3/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1324-3

Other articles of this Issue 3/2017

Endocrine 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.